|
#258 Preventing Adverse Effects of Radiotherapy with CBLB502
|
N43CO900028-000
|
$149,987
|
$49,496
|
Krivokrysenko, Vadim
|
Buffalo BioLabs, LLC
|
|
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
|
1R01CA227473-01
|
$580,767
|
|
HEROLD, KEVAN
|
YALE UNIVERSITY
|
|
(PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiation
|
5R01CA208535-03
|
$506,533
|
|
GROSSHANS, DAVID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ#9): Altered mitochondrial transport and chemotherapy-induced peripheral neuropathy
|
5R21CA215985-02
|
$165,000
|
|
CHANG, KAREN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
|
5R01CA206025-03
|
$630,724
|
|
GUISE, THERESA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
|
5R01CA206026-03
|
$356,850
|
|
WALDMAN, SCOTT
|
THOMAS JEFFERSON UNIVERSITY
|
|
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
|
5R01CA208644-03
|
$377,438
|
|
CRITTENDEN, MARKA
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
|
5R01CA219880-02
|
$670,182
|
|
PALUCKA, ANNA KAROLINA
|
JACKSON LABORATORY
|
|
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer
|
5R01CA206465-03
|
$512,833
|
|
JUSTICE, AMY
|
YALE UNIVERSITY
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ6) Roles of circadian rhythms in tumor development
|
1R21CA227379-01
|
$208,800
|
|
HONG, CHRISTIAN
|
UNIVERSITY OF CINCINNATI
|
|
(PQ6): Is Adrenergic Stress-induced Immune Suppression at the Crossroads of Circadian Rhythm Disruption and Cancer?
|
1R21CA227375-01
|
$224,199
|
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
|
5R01CA205431-03
|
$522,325
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal
|
5R01CA219667-02
|
$523,048
|
|
DUMAN, JOSEPH
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
|
5R01CA208634-03
|
$560,277
|
|
JURECIC, ROLAND
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
|
5R01CA205255-03
|
$577,463
|
|
SEGAL, ROSALIND
|
DANA-FARBER CANCER INST
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors
|
5R01CA194473-04
|
$119,807
|
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQC1) Accelerated biological aging and colon polyp to cancer progression
|
5R01CA194663-04
|
$401,448
|
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
|
5P20CA202923-04
|
$54,305
|
|
KHAN, SOHAIL
|
CHEROKEE NATION
|
|
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132379-09
|
$1,304,869
|
|
MARTINEZ, MARIA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156734-08
|
$1,691,502
|
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
5P20CA192994-04
|
$277,311
|
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer
|
5R01CA195686-03
|
$366,000
|
|
SHUREIQI, IMAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
2/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
|
5P20CA202921-04
|
$289,031
|
|
SPICER, PAUL
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
|
5P20CA192996-04
|
$154,589
|
|
MCCOMBIE, WILLIAM
|
COLD SPRING HARBOR LABORATORY
|
|
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156732-08
|
$1,870,359
|
|
VISWANATH, KASISOMAYAJULA
|
DANA-FARBER CANCER INST
|
|
2/2, University of Guam/University of Hawaii Cancer Center Partnership
|
5U54CA143728-09
|
$977,538
|
|
LEON GUERRERO, RACHAEL
|
UNIVERSITY OF GUAM
|
|
3/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202997-04
|
$1,566,061
|
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
7T Neurosurgical Mapping Protocol for Endoscopic Resection of Skull Base Tumors
|
5R01CA202911-03
|
$387,731
|
|
BALCHANDANI, PRITI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
A 3D Model of the Perivascular Niche to Investigate Glioblastoma Invasion
|
1F31CA228317-01
|
$39,703
|
|
WOLF, KAYLA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Clinical Validation Center for Early Detection of Pancreatic Cancer
|
5U01CA200468-03
|
$760,296
|
|
MAITRA, ANIRBAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A combined single cell gene expression and enzyme activity assay to study chemotherapy resistance in pancreatic ductal adenocarcinoma
|
1F31CA228223-01
|
$35,681
|
|
PETERSEN, BRAE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A Data Resource for Analyzing Blood and Marrow Transplants
|
5U24CA076518-12
|
$2,350,000
|
$2,350,000
|
Horowitz, Mary
|
MEDICAL COLLEGE OF WISCONSIN
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-03
|
$418,127
|
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
A microRNA mediating vascular directed fibrinolysis and tumor progression
|
5F31CA213793-03
|
$33,794
|
|
MCCANN, JAMES
|
UNIVERSITY OF VIRGINIA
|
|
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
|
1R01CA217841-01A1
|
$717,367
|
|
SUN, VIRGINIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Naturalistic Nationwide Randomized Study of e-Cigarette Uptake and Consequences
|
5R01CA210625-02
|
$542,711
|
|
CARPENTER, MATTHEW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
A new imaging approach to radiotherapy planning for lung cancer
|
5R01CA193050-04
|
$577,910
|
|
RIZI, RAHIM
|
UNIVERSITY OF PENNSYLVANIA
|
|
A novel molecular cross-talk driving pancreatic cancer progression
|
1R01CA224306-01
|
$346,556
|
|
SINGH, AJAY
|
UNIVERSITY OF SOUTH ALABAMA
|
|
A Novel Values-based Intervention to Increase Endocrine Therapy Adherence among Breast Cancer Survivors
|
1R21CA218723-01A1
|
$207,450
|
|
ARCH, JOANNA
|
UNIVERSITY OF COLORADO
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
5R21CA205106-02
|
$176,605
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.
|
1R01CA228512-01
|
$504,230
|
|
GIANNAKAKOU, PARASKEVI
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
|
5R01CA217179-02
|
$559,312
|
|
MARKERT, JAMES
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
A prospective examination of change in executive function and physical activity in older breast cancer survivors.
|
1F31CA220964-01A1
|
$42,314
|
|
TOMETICH, DANIELLE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-05
|
$456,456
|
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
A randomized trial of lifestyle guidelines on breast cancer biomarkers and treatment adherence
|
5R01CA207753-02
|
$663,278
|
|
SANFT, TARA
|
YALE UNIVERSITY
|
|
A Standardized Nursing Intervention Protocol for HCT Patients
|
5R01CA107446-04
|
$428,731
|
$214,366
|
GRANT, MARCIA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate Cancer
|
1R01CA226537-01
|
$673,092
|
|
PASQUALINI, RENATA
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A Unique Deployable Thermosensor Probe for the Minimally Invasive Treatment of Renal Tumors
|
1R43CA224431-01A1
|
$300,000
|
|
VAN BUSKIRK, ROBERT
|
CELL PRESERVATION SERVICES, INC.
|
|
Abbreviated MRI Breast Screening protocol
|
5F31CA217160-02
|
$32,943
|
|
JIMENEZ, JORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
Total relevant funding to Bone Marrow Transplantation for this search: $73,246,391
|